TPST: Tempest Therapeutics Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Tempest Therapeutics Inc (TPST).
$36.42M Market Cap.
TPST Market Cap. (MRY)
TPST Shares Outstanding (MRY)
TPST Assets (MRY)
Total Assets
$41.49M
Total Liabilities
$22.36M
Total Investments
$0
TPST Income (MRY)
Revenue
$0
Net Income
-$41.84M
Operating Expense
$42.03M
TPST Cash Flow (MRY)
CF Operations
-$33.03M
CF Investing
-$435.00K
CF Financing
$24.50M
TPST Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $41,488,000 (-19.60%) | $51,603,000 (11.96%) | $46,089,000 (-37.07%) | $73,238,000 (220.33%) |
Assets Current | $31,474,000 (-22.02%) | $40,363,000 (22.50%) | $32,950,000 (-52.22%) | $68,963,000 (247.86%) |
Assets Non-Current | $10,014,000 (-10.91%) | $11,240,000 (-14.45%) | $13,139,000 (207.35%) | $4,275,000 (40.72%) |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Shareholders Equity | $19,126,000 (-28.55%) | $26,768,000 (47.80%) | $18,111,000 (-49.85%) | $36,117,000 (152.50%) |
Property Plant & Equipment Net | $9,529,000 (-11.70%) | $10,792,000 (-15.09%) | $12,710,000 (205.24%) | $4,164,000 (39.40%) |
Cash & Equivalents | $30,268,000 (-22.84%) | $39,230,000 (25.62%) | $31,230,000 (-39.74%) | $51,829,000 (175.39%) |
Accumulated Other Comprehensive Income | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Payables | $2,450,000 (189.94%) | $845,000 (-23.74%) | $1,108,000 (11.81%) | $991,000 (-7.47%) |
Accumulated Retained Earnings (Deficit) | -$207,106,000 (-25.32%) | -$165,263,000 (-21.72%) | -$135,772,000 (-35.69%) | -$100,063,000 (-39.44%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $15,365,000 (-25.63%) | $20,661,000 (-6.57%) | $22,114,000 (19.30%) | $18,537,000 (660.02%) |
Debt Current | $7,223,000 (37.92%) | $5,237,000 (270.63%) | $1,413,000 (-2.01%) | $1,442,000 (102.53%) |
Debt Non-Current | $8,142,000 (-47.21%) | $15,424,000 (-25.49%) | $20,701,000 (21.09%) | $17,095,000 (889.87%) |
Total Liabilities | $22,362,000 (-9.96%) | $24,835,000 (-11.23%) | $27,978,000 (-24.63%) | $37,121,000 (650.07%) |
Liabilities Current | $14,220,000 (51.10%) | $9,411,000 (29.33%) | $7,277,000 (-63.66%) | $20,026,000 (521.54%) |
Liabilities Non-Current | $8,142,000 (-47.21%) | $15,424,000 (-25.49%) | $20,701,000 (21.09%) | $17,095,000 (889.87%) |
TPST Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $13,550,000 (16.22%) | $11,659,000 (-3.75%) | $12,113,000 (23.35%) | $9,820,000 (100.04%) |
Research & Development Expense | $28,476,000 (62.74%) | $17,498,000 (-22.32%) | $22,527,000 (31.23%) | $17,166,000 (19.30%) |
Operating Expenses | $42,026,000 (44.14%) | $29,157,000 (-15.83%) | $34,640,000 (28.36%) | $26,986,000 (39.84%) |
Interest Expense | $1,316,000 (-9.18%) | $1,449,000 (-10.44%) | $1,618,000 (26.21%) | $1,282,000 (1524.44%) |
Income Tax Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$41,843,000 (-41.88%) | -$29,491,000 (17.41%) | -$35,709,000 (-26.17%) | -$28,302,000 (-47.34%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$41,843,000 (-41.88%) | -$29,491,000 (17.41%) | -$35,709,000 (-26.17%) | -$28,302,000 (-47.34%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$41,843,000 (-41.88%) | -$29,491,000 (17.41%) | -$35,709,000 (-26.17%) | -$28,302,000 (-47.34%) |
Weighted Average Shares | $2,146,288 (80.99%) | $1,185,862 (33.49%) | $888,377 (204.70%) | $291,562 (709.62%) |
Weighted Average Shares Diluted | $2,146,288 (80.99%) | $1,185,862 (33.49%) | $888,377 (204.70%) | $291,562 (709.62%) |
Earning Before Interest & Taxes (EBIT) | -$40,527,000 (-44.52%) | -$28,042,000 (17.74%) | -$34,091,000 (-26.17%) | -$27,020,000 (-40.01%) |
Gross Profit | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Operating Income | -$42,026,000 (-44.14%) | -$29,157,000 (15.83%) | -$34,640,000 (-28.36%) | -$26,986,000 (-39.84%) |
TPST Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | -$435,000 (-155.88%) | -$170,000 (69.75%) | -$562,000 (-479.38%) | -$97,000 (-1516.67%) |
Net Cash Flow from Financing | $24,500,000 (-31.18%) | $35,602,000 (212.22%) | $11,403,000 (-80.69%) | $59,063,000 (70.71%) |
Net Cash Flow from Operations | -$33,027,000 (-20.73%) | -$27,357,000 (11.96%) | -$31,072,000 (-19.71%) | -$25,957,000 (-36.49%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$8,962,000 (-210.98%) | $8,075,000 (139.91%) | -$20,231,000 (-161.29%) | $33,009,000 (111.92%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $38,000 (-13.64%) |
Capital Expenditure | -$435,000 (-155.88%) | -$170,000 (69.75%) | -$562,000 (-316.30%) | -$135,000 (-170.00%) |
Issuance (Repayment) of Debt Securities | -$4,398,000 (0%) | $0 (0%) | -$4,739,000 (-131.59%) | $15,000,000 (0%) |
Issuance (Purchase) of Equity Shares | $28,898,000 (-18.83%) | $35,602,000 (120.56%) | $16,142,000 (-63.44%) | $44,158,000 (64838.24%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Share Based Compensation | $5,303,000 (108.29%) | $2,546,000 (63.10%) | $1,561,000 (41.27%) | $1,105,000 (143.93%) |
Depreciation Amortization & Accretion | $1,698,000 (-18.33%) | $2,079,000 (14.61%) | $1,814,000 (42.83%) | $1,270,000 (55.83%) |
TPST Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | - | - | - | - |
Profit Margin | - | - | - | - |
EBITDA Margin | - | - | - | - |
Return on Average Equity (ROAE) | -245.60% (13.49%) | -283.90% (-117.05%) | -130.80% (-76.52%) | -74.10% (33.96%) |
Return on Average Assets (ROAA) | -103.40% (-25.94%) | -82.10% (-42.29%) | -57.70% (-26.26%) | -45.70% (-17.18%) |
Return on Sales (ROS) | - | - | - | - |
Return on Invested Capital (ROIC) | -244.40% (-127.99%) | -107.20% (40.48%) | -180.10% (1.75%) | -183.30% (86.69%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -0.56 (75.87%) | -2.3 (-519.35%) | -0.37 (47.38%) | -0.71 (9.59%) |
Price to Sales Ratio (P/S) | - | - | - | - |
Price to Book Ratio (P/B) | 1.9 (-39.82%) | 3.16 (373.65%) | 0.67 (-33.86%) | 1.01 (270.90%) |
Debt to Equity Ratio (D/E) | 1.17 (25.97%) | 0.93 (-39.94%) | 1.54 (50.29%) | 1.03 (1527.78%) |
Earnings Per Share (EPS) | -19.5 (21.47%) | -24.83 (38.19%) | -40.17 (58.63%) | -97.11 (81.79%) |
Sales Per Share (SPS) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Free Cash Flow Per Share (FCFPS) | -15.59 (32.84%) | -23.21 (34.81%) | -35.61 (60.21%) | -89.49 (83.10%) |
Book Value Per Share (BVPS) | 8.91 (-60.52%) | 22.57 (10.72%) | 20.39 (-83.54%) | 123.87 (106.48%) |
Tangible Assets Book Value Per Share (TABVPS) | 19.33 (-55.58%) | 43.52 (-16.12%) | 51.88 (-79.35%) | 251.19 (-60.43%) |
Enterprise Value Over EBIT (EV/EBIT) | -1 (66.67%) | -3 (0%) | 0 (0%) | 0 (0%) |
Enterprise Value Over EBITDA (EV/EBITDA) | -0.82 (77.35%) | -3.64 (-941.34%) | 0.43 (150.29%) | 0.17 (4225.00%) |
Asset Turnover | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Current Ratio | 2.21 (-48.40%) | 4.29 (-5.28%) | 4.53 (31.48%) | 3.44 (-44.03%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$33,462,000 (-21.56%) | -$27,527,000 (12.98%) | -$31,634,000 (-21.24%) | -$26,092,000 (-36.84%) |
Enterprise Value (EV) | $32,041,309 (-66.12%) | $94,576,978 (776.21%) | -$13,986,336 (-213.56%) | -$4,460,489 (-6398.38%) |
Earnings Before Tax (EBT) | -$41,843,000 (-41.88%) | -$29,491,000 (17.41%) | -$35,709,000 (-26.17%) | -$28,302,000 (-47.34%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$38,829,000 (-49.56%) | -$25,963,000 (19.56%) | -$32,277,000 (-25.35%) | -$25,750,000 (-39.32%) |
Invested Capital | $12,365,000 (-47.66%) | $23,623,000 (-20.45%) | $29,696,000 (49.08%) | $19,920,000 (511.04%) |
Working Capital | $17,254,000 (-44.26%) | $30,952,000 (20.56%) | $25,673,000 (-47.54%) | $48,937,000 (194.75%) |
Tangible Asset Value | $41,488,000 (-19.60%) | $51,603,000 (11.96%) | $46,089,000 (-37.07%) | $73,238,000 (220.33%) |
Market Capitalization | $36,419,309 (-57.00%) | $84,688,978 (600.22%) | $12,094,664 (-66.85%) | $36,486,511 (-10.26%) |
Average Equity | $17,038,500 (64.01%) | $10,388,750 (-61.94%) | $27,293,250 (-28.52%) | $38,181,750 (123.09%) |
Average Assets | $40,467,750 (12.68%) | $35,915,250 (-41.97%) | $61,891,000 (-0.01%) | $61,896,000 (25.76%) |
Invested Capital Average | $16,580,750 (-36.60%) | $26,152,000 (38.15%) | $18,929,500 (28.44%) | $14,738,000 (951.78%) |
Shares | 3,357,082 (126.74%) | 1,480,577 (83.01%) | 809,008 (52.19%) | 531,563 (445.56%) |
